EL-02 · Research peptide
EL-02 · Research peptide
| Molecule | Retatrutide (LY3437943, GGG triagonist) |
| Sequence | Synthetic 39-amino-acid peptide (proprietary) |
| Molecular weight | approximately 4.91 kDa |
| Form | Lyophilized powder |
| Fill per vial | 10 mg / 15 mg / 20 mg / 30 mg / 50 mg |
| Purity | ≥99 % (HPLC) |
Every production lot of Retatrutide passes an HPLC purity assay together with an identity check confirming the expected molecular mass. The two results are combined into a lot-specific certificate of analysis that references the batch number printed on the vial label. This certificate is issued on request through the support team rather than included in every shipment by default.
Keep the lyophilized vial refrigerated at 2 to 8 °C and shielded from light until it is prepared in the laboratory. After reconstitution with a suitable sterile solvent, use the solution promptly within the working session; it is not intended for extended storage once dissolved. No volume or concentration guidance is given here, since reconstitution parameters are set by the receiving laboratory's own protocol.
Retatrutide is supplied strictly for research use (RUO) and is not intended for administration to humans or animals, nor is it a medicinal product, food, or cosmetic ingredient. Compliant handling and use fall entirely to the receiving institution. The literature classifies the molecule as a triple agonist spanning GLP-1, GIP, and glucagon receptor pathways, and it is examined within in vitro receptor pharmacology and metabolic signaling models.
To obtain the certificate of analysis for a particular lot, email Eurolabs Peptides support and quote the batch number found on the vial label. The document covers the HPLC chromatogram and the identity confirmation recorded for that production run.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.41% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Retatrutide is supplied at ≥99 % purity as determined by HPLC. Each production lot is analyzed individually, and the specific result for a given batch is documented in the lot's certificate of analysis.
Retatrutide is offered as lyophilized powder in five fill sizes: 10 mg, 15 mg, 20 mg, 30 mg, and 50 mg per vial, allowing researchers to match the quantity to their experimental design.
Store the unopened, lyophilized vial refrigerated at 2 to 8 °C, protected from light. No storage recommendation is given for reconstituted material beyond prompt use in the laboratory.
Yes. A lot-specific CoA covering HPLC purity and identity confirmation can be requested from support by providing the batch number printed on the vial label.
No reviews yet. Be the first to share your experience.
Tier I · Synthesis QC
Tier I · Synthesis QC
In-house · per step
RP-HPLC, MS confirmation, sequence verification in cleanroom.
Tier II · In-process
Tier II · In-process
Batch · final
Identity, purity, and assay before release.
Tier III · Third-party lab
Tier III · Third-party lab
External · independent
HPLC, ICP-MS, and microbiology by accredited lab.
953
satisfied
99.41%
Avg. purity 2026
4.8 ★
Store rating
EL-02 · Reference data
GLP-1 / GIP / Glucagon Triagonist
Aliases: LY3437943
Research Use Only (RUO)
Research Use Only
For research purposes only (RUO). Not for human consumption.
0.9% benzyl alcohol
€14.99